ketoconazole has been researched along with Patency of the Ductus Arteriosus in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotton, RB | 1 |
| Shah, LP | 1 |
| Poole, SD | 1 |
| Ehinger, NJ | 1 |
| Brown, N | 1 |
| Shelton, EL | 1 |
| Slaughter, JC | 1 |
| Baldwin, HS | 1 |
| Paria, BC | 1 |
| Reese, J | 1 |
1 other study available for ketoconazole and Patency of the Ductus Arteriosus
| Article | Year |
|---|---|
Cimetidine-associated patent ductus arteriosus is mediated via a cytochrome P450 mechanism independent of H2 receptor antagonism.
Topics: Cimetidine; Cytochrome P-450 Enzyme System; Ductus Arteriosus, Patent; Histamine H2 Antagonists; Hum | 2013 |